These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 30690341)

  • 1. Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack.
    Yang X; Huang Q; Yang H; Liu S; Chen B; Liu T; Yang J; Yao H; Lin S; Chen X; Zhuang H; Long Y; Gao C
    Mult Scler Relat Disord; 2019 Apr; 29():94-99. PubMed ID: 30690341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage.
    Hyun JW; Kim Y; Kim KH; Kim SH; Olesen MN; Asgari N; Siritho S; Paul F; Kim HJ
    J Neuroinflammation; 2022 Apr; 19(1):86. PubMed ID: 35413922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: Retrospective research of clinical practice, biomarkers, and pathology.
    Lin PH; Yao HY; Huang L; Fu CC; Yao XL; Lian C; Zhang SF; Lai WD; Lin GY; Liao S; Yang J; Mao ZF; Liu D; Long BY; Yue JJ; Gao C; Long YM
    CNS Neurosci Ther; 2024 Sep; 30(9):e70042. PubMed ID: 39279053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD.
    Kleerekooper I; Herbert MK; Kuiperij HB; Sato DK; Fujihara K; Callegaro D; Marignier R; Saiz A; Senel M; Tumani H; De Jong BA; Trip SA; Nakashima I; Verbeek MM; Petzold A
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):605-611. PubMed ID: 32217788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD and AQP4-IgG
    Xiao J; Zhang SQ; Chen X; Tang Y; Chen M; Shang K; Deng G; Qin C; Tian DS
    Mult Scler Relat Disord; 2022 Oct; 66():104057. PubMed ID: 35870369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
    Masaki K; Suzuki SO; Matsushita T; Yonekawa T; Matsuoka T; Isobe N; Motomura K; Wu XM; Tabira T; Iwaki T; Kira J
    Acta Neuropathol; 2012 Jun; 123(6):887-900. PubMed ID: 22438105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.
    Schindler P; Aktas O; Ringelstein M; Wildemann B; Jarius S; Paul F; Ruprecht K
    Expert Rev Clin Immunol; 2023 Jan; 19(1):71-91. PubMed ID: 36378751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders.
    Wei Y; Chang H; Li X; Du L; Xu W; Cong H; Yao Y; Zhang X; Yin L
    Biomed Res Int; 2018; 2018():5381239. PubMed ID: 30426010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics, immunological alteration and distinction of MOG-IgG-associated disorders and GFAP-IgG-associated disorders.
    Zeng R; He L; Kuang Z; Jian Y; Qiu M; Liu Y; Hu M; Ye Y; Wu L
    J Neuroimmunol; 2024 Aug; 393():578398. PubMed ID: 39002186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.
    Kaneko K; Sato DK; Nakashima I; Ogawa R; Akaishi T; Takai Y; Nishiyama S; Takahashi T; Misu T; Kuroda H; Tanaka S; Nomura K; Hashimoto Y; Callegaro D; Steinman L; Fujihara K; Aoki M
    J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):927-936. PubMed ID: 29875186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder.
    Akaishi T; Takahashi T; Misu T; Kaneko K; Takai Y; Nishiyama S; Ogawa R; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakashima I
    Neurology; 2021 Jul; 97(1):e1-e12. PubMed ID: 33980704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease.
    Kim H; Lee EJ; Kim S; Choi LK; Kim K; Kim HW; Kim KK; Lim YM
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32184342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy.
    Ding J; Ren K; Wu J; Li H; Sun T; Yan Y; Guo J
    J Neurol; 2020 Sep; 267(9):2589-2593. PubMed ID: 32378036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
    Lucchinetti CF; Guo Y; Popescu BF; Fujihara K; Itoyama Y; Misu T
    Brain Pathol; 2014 Jan; 24(1):83-97. PubMed ID: 24345222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting with Slowly Progressive Myelitis and Longitudinally Extensive Spinal Cord Lesions.
    Kudo T; Kimura A; Higashida K; Yamada M; Hayashi Y; Shimohata T
    Intern Med; 2020 Nov; 59(21):2777-2781. PubMed ID: 32669494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Immunohistopathology in a Patient with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.
    Shu Y; Long Y; Chang Y; Li R; Sun X; Wang Y; Huang Y; Li J; Chen J; Yang Y; Lu Z; Hu X; Kermode AG; Qiu W
    Neuroimmunomodulation; 2018; 25(1):1-6. PubMed ID: 29788018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.
    Misu T; Takano R; Fujihara K; Takahashi T; Sato S; Itoyama Y
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):575-7. PubMed ID: 19372295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting with Area Postrema Syndrome-Like Symptoms without Medulla Oblongata Lesions.
    Iwami K; Nomura T; Seo S; Nojima S; Tsuzaka K; Kimura A; Shimohata T; Yabe I
    Neuroimmunomodulation; 2022; 29(4):433-438. PubMed ID: 35421859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature.
    Shan F; Long Y; Qiu W
    Front Immunol; 2018; 9():2802. PubMed ID: 30568655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.